Latest News and Press Releases
Want to stay updated on the latest news?
-
Appointment of Chief Scientific OfficerDr. David Ruau joins Sensyne Health from Bayer Pharmaceuticals Oxford, U.K. 22 July 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company”), the...
-
Sensyne Health Interim Results Oxford, UK; 21 January 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces its Interim Results...
-
Sensyne Health appoints President, North America, to lead US expansion Oxford, U.K. 13 November 2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical...
-
Sensyne Health Full Year Results Oxford, U.K. 30 September 2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces its audited...
-
Sensyne Health announces the UK launch of ‘SENSETM’ - a clinical algorithm engine, created in partnership with Microsoft ‘SENSETM’ provides a real-time decision support service for clinicians across...
-
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...
-
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and...
-
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States Entry to US market grows Sensyne Health database on...
-
Sensyne Health and Wye Valley NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 1.36 million hospital admissions, for analysis using...
-
Sensyne Health and George Eliot Hospital NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 746,000 hospital admissions, for analysis...